Suchergebnisse - "Behera, Amulyaratna"

PubPharm (12)

1

Evaluation of ABO Blood Groups System with Infection to Hepatitis C Virus: A Tertiary Hospital Study in India

enthalten in: ResearchSquare.com | 2024

von Manasa, K. | Pattnaik, G. | Rao, Y. | +2

2

Evaluation of ABO Blood Groups System with Infection to Hepatitis C Virus: A Tertiary Hospital Study in India

enthalten in: ResearchSquare.com | 2024

von Manasa, K. | Pattnaik, G. | Rao, Y. | +2

3

Perspectives on chick embryo models in developmental and reproductive toxicity screening

enthalten in: Reproductive toxicology (Elmsford, N.Y.) | 2024

von Acharya, B. | Dey, S. | Sahu, P. | +3

4

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders

enthalten in: ACS applied bio materials | 2024

von Acharya, B. | Behera, A. | Behera, S. | +1

5

Development of microemulgel formulations with varied permeation enhancers for transungual delivery of luliconazole in onychomycosis management

enthalten in: Colloids and surfaces. B, Biointerfaces | 2024

von Giri, Y. | Habibullah, S. | Dixit, P. | +3

6

RP HPLC Enabled Novel Analytical Method for the Development and Quantification of Cefuroxime Axetil in its Bulk Drug and Pharmaceutical Formulations

enthalten in: Macromolecular Symposia | 2024

von Mishra, H. | Behera, A. | Kar, S. | +1

7

Analytical Method Development and Validation of a UV‐Spectrophotometric Technique for Pioglitazone HCL Estimation in Bulk and Polymeric Nanoparticles

enthalten in: Macromolecular Symposia | 2024

von Sharma, D. | Pattnaik, G. | Behera, A.

8

Recent developments in nanoparticles for the treatment of diabetes

enthalten in: Journal of drug targeting | 2023

von Sharma, D. | Pattnaik, G. | Behera, A.

9

Development and Optimization of Cefuroxime Axetil Nanosuspension for Improved Oral Bioavailability: In-Vitro and In-Vivo Investigations

enthalten in: BioNanoScience | 2023

von Mishra, H. | Behera, A. | Kar, S. | +3

10

NOX-2 Inhibitors may be Potential Drug Candidates for the Management of COVID-19 Complications

enthalten in: Current drug research reviews | 2023

von Chowdhury, B. | Sahoo, B. | Jena, A. | +3